539428 TEJNAKSH

Tejnaksh Healthcare Share Price

 

 

Start SIP in TEJNAKSH

Start SIP
Tejnaksh Healthcare live price: ₹13.83. It opened at ₹15 vs previous close ₹15; intraday high/low: ₹15/₹14. The 50 & 200 DMA stand at ₹14.37/₹17.14.

Tejnaksh Healthcare Performance

  • Low
  • ₹14
  • High
  • ₹15
  • 52 Week Low
  • ₹12
  • 52 Week High
  • ₹25
  • Open Price₹15
  • Previous Close₹15
  • Volume12,753
  • 50 DMA₹14.37
  • 100 DMA₹15.32
  • 200 DMA₹17.14

Investment Returns

  • Over 1 Month -2.4%
  • Over 3 Month -7.31%
  • Over 6 Month -25.36%
  • Over 1 Year -39.42%

Smart Investing Starts Here Start SIP with Tejnaksh Healthcare for Steady Growth!

Invest Now

Tejnaksh Healthcare Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 20.6
  • PEG Ratio
  • -0.5
  • Market Cap Cr
  • 28
  • P/B Ratio
  • 1
  • Average True Range
  • 1.1
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.24
  • RSI
  • 48.68
  • MFI
  • 71.19

Tejnaksh Healthcare Financials

Tejnaksh Healthcare Technicals

EMA & SMA

Current Price
₹13.83
-1.11 (-7.43%)
pointer
  • Bearish Moving Average 14
  • Bullish Moving Average 2
  • 20 Day
  • ₹13.92
  • 50 Day
  • ₹14.37
  • 100 Day
  • ₹15.32
  • 200 Day
  • ₹17.14

Resistance and Support

14.29 Pivot Speed
  • R3 17.02
  • R2 16.26
  • R1 15.05
  • S1 13.08
  • S2 12.32
  • S3 11.11

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Tejnaksh Healthcare has an operating revenue of Rs. 11.45 Cr. on a trailing 12-month basis. An annual revenue growth of 7% is good, Pre-tax margin of 25% is great, ROE of 8% is fair but needs improvement. The company has a reasonable debt to equity of 2%, which signals a healthy balance sheet. From an O'Neil Methodology perspective, the stock has an EPS Rank of 21 which is a POOR score indicating inconsistency in earnings, a RS Rating of 44 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 60 indicates it belongs to a fair industry group of Medical-Hospitals and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Tejnaksh Healthcare Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-02-07 Quarterly Results
2025-11-08 Quarterly Results
2025-08-14 Quarterly Results
2025-05-29 Audited Results
2025-04-12 Others To pprove, the draft letter and authorized its filing on-line with BSE for their approval, the designated Stock Exchange as per applicable provisions of SEBI ICDR, 2018. split from Rs. 10/- to Rs. 5/-.
Date Purpose Remarks
2023-07-19 Split Rs.0.00 split from Rs. 10/- to Rs. 5/-.

Tejnaksh Healthcare F&O

Tejnaksh Healthcare Shareholding Pattern

73.83%
23.72%
2.45%

About Tejnaksh Healthcare

  • NSE Symbol
  • TEJNAKSH
  • BSE Symbol
  • 539428
  • Managing Director
  • Dr. Ashish Vishwas Rawandale
  • ISIN
  • INE030T01027

Similar Stocks to Tejnaksh Healthcare

Tejnaksh Healthcare FAQs

Tejnaksh Healthcare share price is ₹13 As on 17 March, 2026 | 20:22

The Market Cap of Tejnaksh Healthcare is ₹28.1 Cr As on 17 March, 2026 | 20:22

The P/E ratio of Tejnaksh Healthcare is 20.6 As on 17 March, 2026 | 20:22

The PB ratio of Tejnaksh Healthcare is 1 As on 17 March, 2026 | 20:22

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23